Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

The neonatal kidney: implications for drug metabolism and elimination.

Ligi I, Boubred F, Grandvuillemin I, Simeoni U.

Curr Drug Metab. 2013 Feb;14(2):174-7. Review.

PMID:
22935066
2.

Principles and clinical application of assessing alterations in renal elimination pathways.

Tett SE, Kirkpatrick CM, Gross AS, McLachlan AJ.

Clin Pharmacokinet. 2003;42(14):1193-211. Review.

PMID:
14606929
3.

Preterm birth and the kidney: implications for long-term renal health.

Gubhaju L, Sutherland MR, Black MJ.

Reprod Sci. 2011 Apr;18(4):322-33. doi: 10.1177/1933719111401659. Review.

PMID:
21427457
4.

Development of mechanisms for drug excretion.

Hook JB, Hewitt WR.

Am J Med. 1977 Apr;62(4):497-506.

PMID:
851120
5.

Renal development and neonatal adaptation.

Saint-Faust M, Boubred F, Simeoni U.

Am J Perinatol. 2014 Oct;31(9):773-80. doi: 10.1055/s-0033-1361831. Epub 2014 Mar 12. Review.

PMID:
24623338
6.

The interplay between drugs and the kidney in premature neonates.

Schreuder MF, Bueters RR, Allegaert K.

Pediatr Nephrol. 2014 Nov;29(11):2083-91. doi: 10.1007/s00467-013-2651-0. Epub 2013 Nov 12. Review.

PMID:
24217783
7.

Ontogeny of hepatic and renal systemic clearance pathways in infants: part II.

Alcorn J, McNamara PJ.

Clin Pharmacokinet. 2002;41(13):1077-94. Review.

PMID:
12403644
8.

Ontogeny of drug elimination by the human kidney.

Chen N, Aleksa K, Woodland C, Rieder M, Koren G.

Pediatr Nephrol. 2006 Feb;21(2):160-8. Epub 2005 Dec 6. Review.

PMID:
16331517
9.

Determinants of variability in clearance of exogenous compounds in neonates.

Allegaert K, Van Den Anker JN, Tayman C, De Hoon J.

Verh K Acad Geneeskd Belg. 2009;71(3):141-64.

PMID:
20088252
10.

Assessment of kidney function in preterm infants: lifelong implications.

Abitbol CL, DeFreitas MJ, Strauss J.

Pediatr Nephrol. 2016 Dec;31(12):2213-2222. Epub 2016 Feb 4.

PMID:
26846786
11.

[Renal function and pharmacotherapy in children].

Jovanović O.

Srp Arh Celok Lek. 1995 Jun;123 Suppl 1:15-21. Review. Serbian.

PMID:
18193796
12.

Drug disposition during the perinatal period.

Heimann G.

Int J Biol Res Pregnancy. 1981;2(1):1-14.

PMID:
7341492
13.

Ontogeny of hepatic and renal systemic clearance pathways in infants: part I.

Alcorn J, McNamara PJ.

Clin Pharmacokinet. 2002;41(12):959-98. Review.

PMID:
12222995
14.

Why do newborn infants have a high plasma creatinine?

Guignard JP, Drukker A.

Pediatrics. 1999 Apr;103(4):e49.

PMID:
10103341
15.

Principles of drug administration in renal insufficiency.

Lam YW, Banerji S, Hatfield C, Talbert RL.

Clin Pharmacokinet. 1997 Jan;32(1):30-57. Review.

PMID:
9012555
16.

Effects of early postnatal hypernutrition on nephron number and long-term renal function and structure in rats.

Boubred F, Buffat C, Feuerstein JM, Daniel L, Tsimaratos M, Oliver C, Lelièvre-Pégorier M, Simeoni U.

Am J Physiol Renal Physiol. 2007 Dec;293(6):F1944-9. Epub 2007 Sep 26.

17.

Marked interindividual variability in renal maturation of preterm infants: lessons from autopsy.

Faa G, Gerosa C, Fanni D, Nemolato S, Locci A, Cabras T, Marinelli V, Puddu M, Zaffanello M, Monga G, Fanos V.

J Matern Fetal Neonatal Med. 2010 Oct;23 Suppl 3:129-33. doi: 10.3109/14767058.2010.510646.

PMID:
20836739
18.

Short-term gestation, long-term risk: prematurity and chronic kidney disease.

Carmody JB, Charlton JR.

Pediatrics. 2013 Jun;131(6):1168-79. doi: 10.1542/peds.2013-0009. Epub 2013 May 13. Review.

19.

Mechanisms and clinical implications of renal drug excretion.

Masereeuw R, Russel FG.

Drug Metab Rev. 2001 Aug-Nov;33(3-4):299-351. Review.

PMID:
11768771
20.

Disparities in renal endowment: causes and consequences.

Ingelfinger JR.

Adv Chronic Kidney Dis. 2008 Apr;15(2):107-14. doi: 10.1053/j.ackd.2008.01.003. Review.

PMID:
18334234

Supplemental Content

Support Center